- Report
- October 2024
- 198 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 93 Pages
Global
From €5324EUR$5,600USD£4,472GBP
- Report
- November 2024
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- October 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- December 2021
- 81 Pages
Global
From €5656EUR$5,950USD£4,752GBP
- Report
- February 2024
- 86 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Book
- August 2022
Global
Minimally Invasive Thoracic Surgery (MITS) is a type of surgery that is performed through small incisions in the chest wall. It is used to treat a variety of conditions, including lung cancer, emphysema, and pleural effusions. The procedure is less invasive than traditional open thoracic surgery, resulting in less pain, shorter hospital stays, and faster recovery times. It also reduces the risk of infection and other complications.
MITS is performed using a variety of specialized instruments, including endoscopes, robotic arms, and video cameras. These tools allow surgeons to access the chest cavity without making large incisions. The procedure is often performed in conjunction with other treatments, such as chemotherapy and radiation therapy.
Several companies specialize in the development and manufacture of MITS instruments and technologies. These include Intuitive Surgical, Medtronic, Stryker, and Smith & Nephew. These companies provide a range of products, including robotic arms, endoscopes, and video cameras, to help surgeons perform the procedure safely and effectively. Show Less Read more